Art Therapy Intervention for Breast Cancer Patients
As studies continue to debate the effects of quality of life on survival, increased attention is being focused on investigating complementary alternative therapies to boost overall total health in cancer patients . Art therapy is an interesting growing field, which has shown promise to positively influence quality of life in the pediatric and adult oncology population alike. As there is a paucity of well controlled complete studies in this field, the investigators propose to study the impact of art therapy sessions in women with breast cancer with quantitative and qualitative analysis of emotional health and physical symptoms.
The results of the investigators study will have widespread applicability to oncology programs that wish to offer/implement such sessions to their palliative and non-palliative outpatients in an effort to address the important concept of whole person care.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||A Mixed Methods Approach to Evaluating How Art Therapy Can Benefit Women Recently Diagnosed With Breast Cancer|
- Quality of Life (emotional distress, physical symptoms,self-efficacy and well-being) [ Time Frame: 8 weeks ]
To investigate whether the implementation of an 8 week art therapy course in post-operative outpatient breast cancer patients can alleviate/improve
- Emotional distress as assessed by the Hospital Depression and Anxiety Scale (HADS) (please see below for details)
- Physical symptoms as assessed by the Edmonton Symptom Assessment Scale (ESAS)
- Meaning making as assessed by The Generalized Self-Efficacy Scale (GSES) and the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp-12).
- Ability to find and create meaning after the psychosocial impact of a breast cancer diagnosis [ Time Frame: 8 weeks ]To investigate qualitatively how group art therapy can address the psychosocial impacts of breast cancer, including the challenges of finding and creating meaning following a recent diagnosis of breast cancer.
|Study Start Date:||August 2010|
|Study Completion Date:||October 2013|
|Primary Completion Date:||December 2012 (Final data collection date for primary outcome measure)|
Experimental: Art Therapy intervention group
For participants who will be part of the art therapy intervention, the art therapy group will be a closed group for eight women with breast cancer who are in treatment and recently have had surgery. The group will meet once a week for two hours over a period of 8 weeks, and will focus on exploring the expressive capabilities of art making in a supportive group. This group will be held in the conference room at the Cedars Breast Clinic. Each week will revolve around a theme that pertains to the experience of women living with breast cancer, and will be guided by the women's needs in the group. A broad range of art materials will be made available and various art techniques explored. No art experience is necessary. The intervention group will also need to fill out simple questionnaires before the art therapy groups starts and after the group finishes
Other: art therapy
Art therapy sessions, 2 hours in duration, 1 session/week, 8 continuous weeks of sessions. Each group will be limited to eight women as space is limited.
No Intervention: Control Group
The group not assigned to the intervention group will be asked to fill out questionnaires at two separate times (before and after the intervention group is run). The Control group will be offered the opportunity to join an open art therapy group upon completing the questionnaires.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01220960
|Cedars Breast Centre\ Royal Victoria Hospital|
|Montreal, Quebec, Canada, H3A 1A1|
|Principal Investigator:||Katherine L Laux, MA Art Therapy||Cedars CanSupport|
|Principal Investigator:||Virginia Lee, PhD||McGill University Health Center|
|Principal Investigator:||Sharon Wexler, PhD||Cedars CanSupport|
|Principal Investigator:||Monisha Sudarshan, MD||McGill University Health Center|
|Study Director:||Sarkis Meterissian, PhD||MUHC Cedars Breast Centre|